American Virtual Cloud (AVCT)

Technical Analysis Historical Data Financials News & Analysis

AVCT NEWS

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting By AVACTA - 3 days ago

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data … [+5414 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		182.89 -0.35
-0.19%
CVX 		136.26 0.2
0.15%
CAT 		313.96 4.69
1.52%
INTC 		19.98 -0.12
-0.6%
MSFT 		425.4 30.14
7.63%
DIS 		90.81 -0.14
-0.15%
DOW 		30.53 -0.06
-0.2%
CSCO 		58.12 0.39
0.68%
GS 		553.83 6.28
1.15%